Playback speed
10 seconds
This video is featured in the 2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CheckMate 67T Trial - Safety & PROs of Subcutaneous vs. IV Nivo in Previously Treated Advanced or Metastatic ccRCC"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Maria Bourlon
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Maria Bourlon
83 views
June 7, 2024
Chapters
CheckMate 67T Study Overview & Endpoints
00:00
Safety, Immunogenicity & Patient Experiences
01:12
Login to view comments.
Click here to Login